Results 251 to 260 of about 23,640 (262)
Some of the next articles are maybe not open access.

Mepolizumab in the Treatment of Severe Eosinophilic Asthma

Immunotherapy, 2016
Alfredo Chetta   +2 more
exaly  

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Pediatric Pulmonology, 2019
Robert Price   +2 more
exaly  

<p>New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic</p>

Biologics: Targets and Therapy, 2019
Marco Caminati   +2 more
exaly  

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis

Medicina (Lithuania), 2019
Toshiyuki Matsuyama   +2 more
exaly  

Aerodigestive eosinophils in children with severe uncontrolled asthma

Annals of Allergy, Asthma & Immunology
Jessica L. Erkman   +4 more
openaire   +2 more sources

Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology: in Practice
Yuto Hamada   +2 more
exaly  

Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology: in Practice
Linda Green   +2 more
exaly  

Home - About - Disclaimer - Privacy